SJS Investment Consulting’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Buy
4,507
+98
+2% +$22.8K 0.12% 45
2026
Q1
$1.08M Sell
4,409
-90
-2% -$21K 0.13% 43
2025
Q4
$931K Buy
4,499
+2
+0% +$395 0.12% 50
2025
Q3
$834K Buy
4,497
+1,541
+52% +$264K 0.11% 54
2025
Q2
$452K Sell
2,956
-138
-4% -$21.2K 0.07% 65
2025
Q1
$513K Buy
3,094
+76
+3% +$11.9K 0.09% 53
2024
Q4
$436K Sell
3,018
-144
-5% -$22.3K 0.08% 56
2024
Q3
$512K Sell
3,162
-46
-1% -$7.33K 0.09% 52
2024
Q2
$469K Buy
3,208
+3
+0.1% +$446 0.09% 49
2024
Q1
$507K Buy
3,205
+11
+0.3% +$1.75K 0.1% 49
2023
Q4
$501K Buy
3,194
+262
+9% +$40.2K 0.11% 46
2023
Q3
$457K Buy
2,932
+39
+1% +$6.43K 0.11% 44
2023
Q2
$479K Buy
2,893
+53
+2% +$8.55K 0.12% 44
2023
Q1
$440K Sell
2,840
-78
-3% -$12.6K 0.12% 44
2022
Q4
$515K Sell
2,918
-92
-3% -$15.9K 0.15% 40
2022
Q3
$492K Buy
+3,010
New +$509K 0.17% 35
2022
Q1
$461K Buy
2,600
+28
+1% +$4.76K 0.14% 50
2021
Q4
$440K Buy
+2,572
New +$421K 0.13% 50

Other funds holding JNJ

SJS Investment Consulting's JNJ Position: Q2 2026 in Review

SJS Investment Consulting increased its Johnson & Johnson (JNJ) stake by 2.2% in Q2 2026, buying an estimated $22.8K and bringing the position to 4,507 shares worth $1.14M. The position accounts for 0.12% of the portfolio, ranked #45.

SJS Investment Consulting first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 1,966 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • SJS Investment Consulting held 4,507 shares of Johnson & Johnson worth $1.14M as of Q2 2026.
  • SJS Investment Consulting bought 98 Johnson & Johnson shares in Q2 2026, an estimated $22.8K.
  • Johnson & Johnson made up 0.12% of SJS Investment Consulting's portfolio in Q2 2026, its #45 holding.
  • SJS Investment Consulting first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 1,966 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.